Discovery Laboratories Inc. (DSCO) Stock News, Earnings & History

(NASDAQ:DSCO) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 3.51
52wk low: 1.50
EPS: -0.92
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 65.65M
Avg Vol (3m): 360,595

Latest Headlines

More Articles About DSCO →

Company On Twitter

Company Profile

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for Discovery Laboratories Inc..

Yahoo, HV, Market Watch, The Wall St. Journal